Golden Capital Portfolio continues to outperform the benchmark S&P 500 Return On Invested Capital year-to-date. In my most recent update I offered to investors and readers alike my 5-year plus dedication to investing in VIX-leveraged ETPs as the core strategy behind Golden Capital Portfolios strong ROIC. My VIX-leveraged ETF of choice is, and sorry to sound repetitive, ProShares Ultra VIX Short-Term…
Quarterly Update For Golden Capital Portfolio: Tesla Remains In Focus After Quick Profits
A financial market resource for the every-day investor and trader.
-
Corrections and Convictions
Seth Golden, , Research Reports, 0
Somewhere’s in the recess of my childhood memories I can now hear Count Dracula from Sesame Street saying, “1...
-
-
Investor Returns Won’t Prove Easy Hence Forth
Seth Golden, , Research Reports, 0
After 3 full trading weeks, and an additional 3 trading days this past week, the S&P 500 (SPX) managed...
-
Fitbit Beat Q2 2017 Expectations With Channel Inventory Levels Improving
Seth Golden, , Research Reports, 0
Fitbit (FIT) entered its Q2 2017 quarterly report with its stock performing at its lowest valuation since becoming a...
-
Pivotal Week Ahead Of An April Snooze-Fest!
Seth Golden, , Research Reports, 0
The coming week will prove a meaningful earnings week, as the Mega-cap Growth companies will be reporting their quarterly...
-
Fundstrat: March CPI Preview
Seth Golden, , Research Reports, 0
Last week was “stress test” of sorts for equity markets. The combination of “hot” ISM, coupled with Fed members...
-
Weekly Warm-up: Defensive Leadership Can Continue as Earnings Cuts Begin
Seth Golden, , Research Reports, 0
While Defensives are the clear leader, most investors aren’t there, leaving more upside potential as earnings cuts begin. Counter-trend...
-
The Market Roadmap and Investor Returns Can Differ
Seth Golden, , Research Reports, 0
Markets are firmly in the thrawls of another September swoon, which is all-too familiar and painful for many investors....
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00